University of Vermont

The University of Vermont Cancer Center

Other Solid Tumors Clinical Trials

The University of Vermont Cancer Center has many trials specifically focused on solid tumor research.

Status: Active - Recruiting
Study Title: Phase I, First-in-Human, Dose Escalation Trial of MSC2363318A, a Dual p70S6K/Akt Inhibitor, in Subjects with Advanced Malignancies
Purpose: This is a Phase 1, first-in-human, open-label, non-randomized, dose escalation, trial to explore the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical activity signals of MSC2363318A.
ClinicalTrials.gov Identifier: NCT01971515
Primary/Site/Co Investigator:
Contact: Sam Cory (802)-656-9446
Information: http://www.clinicaltrials.gov/ct2/show/NCT01971515?term=01971515&rank=1
Institution Number: CHRMS 14-081
Protocol Research Type: Industry Sponsored
Status: Active - Recruiting
Study Title: EMR100070-001: A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0010718C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications.
Purpose: This is a Phase 1, open-label, dose-escalation trial of MSB0010718C [antibody targeting programmed death ligand 1 (anti PD-L1)] with consecutive parallel group expansion in subjects with selected tumor indications.
ClinicalTrials.gov Identifier: NCT01772004
Primary/Site/Co Investigator:
Contact: Sam Cory (802)-656-9446
Information: http://www.clinicaltrials.gov/ct2/show/NCT01772004?term=NCT01772004&rank=1
Institution Number: CHRMS 14-240
Protocol Research Type: Industry Sponsored

Last modified December 05 2014 11:51 AM